Actualités

Bristol Myers Squibb stock is surging Monday following a report of a potential mega-merger with a competitor.

AstraZeneca stock took a nosedive Monday amid reports it's mulling a mega-merger with Bristol Myers Squibb.

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

A combination of the two pharmaceutical companies could create an entity valued at nearly $400 billion, according to the Financial Times

Investing.com - U.S. stock index futures advanced on Monday after President Donald Trump said negotiations with Iran were set to begin this week, easing geopolitical concerns that had rattled markets in recent weeks, while technology stocks attempted to extend their recovery following July’s sharp pullback.

SoundHound AI has built something rare in the voice-AI space: a platform that major automakers, restaurant chains, banks, and smart TV brands all depend on. Now, with shares down sharply and a transformative merger pending, several trillion-dollar companies have real reasons to consider writing a check.

SpaceX began trading on June 12, 2026, with an IPO price of $135 per share, giving retail investors an opportunity to buy into one of the world’s most closely watched aerospace companies. A $5,000 investment at the IPO price would have purchased about 37.04 shares. By June 16, those shares had climbed to $225.64, increasing […] The post If You Invested $5K in the SpaceX IPO, How Much Do You Have Now? appeared first on SmartReads by SmartAsset.

Palomino Laboratories has completed its acquisition of Vega Links, positioning itself as a key player in the next-generation AI interconnect field. This strategic move significantly expands Palomino's addressable market to over $60 billion and accelerates its capabilities in AI infrastructure. With the integration of Vega Links’ expertise in high-speed AI and memory connectivity, Palomino aims to enhance AI interconnect technologies that improve bandwidth, latency, and power efficiency...

The merger would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of Friday’s close, while Bristol Myers Squibb had a total valuation of $133 billion.

SkyWater will continue serving aerospace, defence, and commercial markets while adding IonQ’s quantum technologies.

Reports indicate AstraZeneca and Bristol-Myers Squibb are in early talks regarding a potential merger. If agreed, the combined group would rank among the largest pharmaceutical companies globally. The discussions are described as preliminary and no formal deal has been announced as at 31 July 2026. Bristol-Myers Squibb, traded as NYSE:BMY, is back in focus as investors consider what a tie up with AstraZeneca could mean for the $65.31 share price. The stock has logged returns of 5.2% over...

If maintained until close, the decline would be the stock’s biggest one-day percentage fall since the day of the 2024 U.S. presidential election.

The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.

United Airlines' failed approaches to Delta and American appear to make little sense. Investors should trust the CEO anyway.

Axon Enterprise has posted consecutive quarter-over-quarter revenue gains, while Chipotle's growth has proven more uneven — a divergence that could reshape investor expectations.

Tesla Inc. CEO Elon Musk has dismissed reports of the EV giant mulling the sale of its Chinese arm that could have reportedly paved the way for a potential merger with Space Exploration Technologies Corp.. Elon Musk Says Sale Has...

Investing.com -- AstraZeneca PLC (NYSE:AZN) and Bristol-Myers Squibb Company (NYSE:BMY) have held talks in recent months about a deal that would combine the companies into one, according to a Financial Times report.

AstraZeneca is plotting a $400bn (£300bn) merger with US rival Bristol Myers Squibb in a deal likely to raise fresh questions over the company’s ties to the UK.

Wall Street finally got a taste of Blackstone-backed Jersey Mike’s, yet the first bite looked hesitant. What’s next for JMKE?

Which of these three high-tech market newcomers is the best?

Morgan Stanley is betting a wave of upcoming IPOs will deliver windfalls worth tens of billions of dollars in client assets for its wealth management...

AvalonBay Communities (AVB) is in focus after updating investors on its share repurchase activity and reporting second quarter 2026 results, along with progress on its planned merger into Vivmark Residential. See our latest analysis for AvalonBay Communities. AvalonBay Communities’ share price has eased in the short term, with a 1-day share price return of 1.16% and 30-day share price return of 2.53%. The 1-year total shareholder return of 4.63% and 3-year total shareholder return of 11.77%...

Is the hot IPO stock finally a bargain?

Video podcasting and gaming could be revenue generators for Netflix, but there isn't anything on the immediate horizon to help reverse stock price losses.

Reports indicate Tesla (NasdaqGS:TSLA) has explored separating its China operations to address regulatory and supply chain issues. The proposed structure could support a future merger with SpaceX, although Elon Musk has firmly denied that such a merger is planned. Internal discussions reportedly focus on cross border rules, manufacturing dependencies, and the role of Tesla's China plant in global output. The situation has gained attention in late July 2026 as investors assess how any...

Chipotle Mexican Grill stock has jumped 17.1% over the past week, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to an overvalued picture. For investors, that recent surge now sits against valuation checks that suggest the share price is running ahead of underlying fundamentals. The 17.1% gain over the last seven days puts fresh momentum behind Chipotle Mexican Grill, which now faces a higher bar for future returns to justify the...

The new CEO took over the conglomerate with a massive nest egg that he must try to deploy.

Robinhood CFO Shiv Verma sits down with Yahoo Finance Executive Editor Brian Sozzi to discuss SpaceX's (SPCX) post-IPO stock moves, as well as how the platform's future IPO access will look.

Is the space stock finally a buy?

NVIDIA and Broadcom just reported back-to-back blowout quarters selling to the same hyperscale customers with opposite strategies, and the gap between their stock reactions tells you something important about where AI infrastructure spending goes next.